CORVAS INTERNATIONAL INC
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: CORVAS INTERNATIONAL INC, 10-Q, EX-10.60, 2000-11-14
Next: PROTEIN DESIGN LABS INC/DE, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           1,263
<SECURITIES>                                    29,597
<RECEIVABLES>                                      474
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                32,046
<PP&E>                                           5,606
<DEPRECIATION>                                   4,560
<TOTAL-ASSETS>                                  33,204
<CURRENT-LIABILITIES>                            3,242
<BONDS>                                         10,770
                                0
                                          0
<COMMON>                                            21
<OTHER-SE>                                      19,065
<TOTAL-LIABILITY-AND-EQUITY>                    33,204
<SALES>                                              0
<TOTAL-REVENUES>                                 5,289
<CGS>                                                0
<TOTAL-COSTS>                                   13,732
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 569
<INCOME-PRETAX>                                 (7,609)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (7,609)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (7,609)
<EPS-BASIC>                                       (.37)
<EPS-DILUTED>                                     (.37)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission